27 results
8-K
CLNN
Clene Inc
19 Sep 23
Departure of Directors or Certain Officers
8:22am
of the Nominating and Corporate Governance Committee of the Board, appointed Professor Matthew Kiernan AM, Ph.D., DSc, and Arjun (JJ) Desai, M.D., as members
424B3
2qct 0m3qu
11 Aug 21
Prospectus supplement
4:01pm
424B3
4zg8hunkrb1ukosc
11 Aug 21
Prospectus supplement
4:00pm
8-K
bwloy6q439ji499bu7
9 Aug 21
Clene Nanomedicine Appoints Dr. Vallerie McLaughlin to its Board of Directors
4:07pm
424B3
5ce4x7eyt7
2 Aug 21
Prospectus supplement
5:03pm
424B3
tz5j lw6f
12 May 21
Prospectus supplement
4:43pm
8-K
hlsxvlj6w
22 Apr 21
Departure of Directors or Certain Officers
12:00am
424B3
nvt18wrgj3
21 Apr 21
Prospectus supplement
6:04am
DEF 14A
9vq b7atrz3yf
5 Apr 21
Definitive proxy
12:00am
10-K
cmn zzp16s
29 Mar 21
Annual report
12:00am
PRE 14A
fqgpoe94en90yxfh
18 Mar 21
Preliminary proxy
4:33pm
S-1
5ybegmy jmm65
17 Feb 21
IPO registration
12:00am
8-K
f0eums14 7pcxqp
5 Jan 21
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update
5:18pm
424B3
f9f089ljym 07n5
18 Dec 20
Prospectus supplement
2:24pm